PH16596A - Use of substituted 1,2,5-oxadiazole 2-oxides for combating or preventing diseases of the cardiovascular system - Google Patents

Use of substituted 1,2,5-oxadiazole 2-oxides for combating or preventing diseases of the cardiovascular system

Info

Publication number
PH16596A
PH16596A PH25459A PH25459A PH16596A PH 16596 A PH16596 A PH 16596A PH 25459 A PH25459 A PH 25459A PH 25459 A PH25459 A PH 25459A PH 16596 A PH16596 A PH 16596A
Authority
PH
Philippines
Prior art keywords
cooc2h5
phenyl
oxadiazole
cooc3h7
cardiovascular system
Prior art date
Application number
PH25459A
Other languages
English (en)
Inventor
Schonafinger Karl
Beyerle Rudi
Mogilev Anton
Eberhard Nitz Rolf
Bohn Helmut
Martorana Piero
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of PH16596A publication Critical patent/PH16596A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH25459A 1980-04-02 1981-04-01 Use of substituted 1,2,5-oxadiazole 2-oxides for combating or preventing diseases of the cardiovascular system PH16596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803012862 DE3012862A1 (de) 1980-04-02 1980-04-02 Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
PH16596A true PH16596A (en) 1983-11-22

Family

ID=6099133

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25459A PH16596A (en) 1980-04-02 1981-04-01 Use of substituted 1,2,5-oxadiazole 2-oxides for combating or preventing diseases of the cardiovascular system

Country Status (8)

Country Link
US (1) US4416893A (ja)
EP (1) EP0038438B1 (ja)
JP (1) JPS56152419A (ja)
AT (1) ATE3613T1 (ja)
AU (1) AU541725B2 (ja)
DE (2) DE3012862A1 (ja)
PH (1) PH16596A (ja)
ZA (1) ZA812178B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134849A1 (de) * 1981-09-03 1983-03-10 Cassella Ag, 6000 Frankfurt 1,2,5-oxadiazol-3,4-dicarbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen
JPS5854878A (ja) * 1981-09-25 1983-03-31 Zojirushi Chain Block Kk 荷役作業機用駆動装置
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4507485A (en) * 1984-01-23 1985-03-26 Bristol-Myers Company 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2 -receptor antagonist activity
DE4217794A1 (de) * 1992-05-29 1993-12-02 Cassella Ag Phenylfuroxane
DE4218582A1 (de) * 1992-06-05 1993-12-09 Cassella Ag Pyridyl-1,2,5-oxadiazol-carbonamid-2-oxide
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4218979A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Pyrimidofuroxane
DE4220264A1 (de) * 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
IT1255207B (it) * 1992-07-03 1995-10-20 Chiesi Farma Spa Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice
DE4223800A1 (de) * 1992-07-20 1994-01-27 Cassella Farbwerke Mainkur Ag Verwendung von 1.2.5-Oxadiazol-2-oxiden zur Behandlung erektiler Dysfunktionen
DE4307105A1 (de) * 1993-03-06 1994-09-08 Cassella Ag Hydroxymethylfurazancarbonsäurederivate
US5460669A (en) * 1993-06-28 1995-10-24 Thiokol Corporation 3-nitramino-4-nitrofurazan and salts thereof
DE4401150A1 (de) * 1994-01-17 1995-07-20 Cassella Ag Furazancarbonsäurederivate
EP1954685A4 (en) * 2005-11-16 2009-11-11 Nitromed Inc FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
AU2009266408C1 (en) * 2008-07-02 2015-12-10 The University Of Queensland Pain-relieving compositions of furoxan NO donors and uses thereof

Also Published As

Publication number Publication date
JPH0223529B2 (ja) 1990-05-24
EP0038438B1 (de) 1983-06-01
DE3160380D1 (en) 1983-07-07
EP0038438A3 (en) 1981-11-04
DE3012862A1 (de) 1981-10-08
JPS56152419A (en) 1981-11-26
AU6899381A (en) 1981-10-08
ZA812178B (en) 1982-04-28
ATE3613T1 (de) 1983-06-15
EP0038438A2 (de) 1981-10-28
US4416893A (en) 1983-11-22
AU541725B2 (en) 1985-01-17

Similar Documents

Publication Publication Date Title
PH16596A (en) Use of substituted 1,2,5-oxadiazole 2-oxides for combating or preventing diseases of the cardiovascular system
NZ237023A (en) 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions
CA2186380A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
SE8300736D0 (sv) Novel pharmacologically active compounds
CA2289717A1 (en) Novel therapy for constipation
CA2115442A1 (en) Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
IL94819A0 (en) 11beta-aryl-4-estrene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
MA19882A1 (fr) Derives d'acides w-amines, leur preparation et utilisation ainsi que les compositions contenant ces acides.
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
RU93053905A (ru) Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
FR2678170B1 (fr) Compositions orales pour la prevention d'odontonecrose et de maladie paradentaire.
EP0031584A3 (en) 2-substituted-aminopropene- and propanenitrile compounds and antimicrobial and pharmaceutical, anti-inflammatory compositions
RU92004562A (ru) Новые цефалоспорины, имеющие в положении 7 замещенный оксииминный радикал, метод их получения и их использование в качестве медикаментов, фармацевтический состав на их основе
FR2505826B1 (fr) Derives d'isoprenylamine et compositions pharmaceutiques preparees avec ces derives
PH19782A (en) Pharmaceutical compositions effective against coronary heart disease and hypertension
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
GB2084017B (en) Pharmaceutical compositions effective against coronary heat disease and hypertension
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
NZ189212A (en) 3-amino substituted 1,5-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions